Application of VGLL4 gene in treatment of tumors and related medicament of VGLL4 gene

A gene and drug technology, applied in the biological field, can solve problems such as excessive cell proliferation and increased risk of cancer

Active Publication Date: 2015-04-29
CENT FOR EXCELLENCE IN MOLECULAR CELL SCI CHINESE ACAD OF SCI
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the disorder of Hippo signaling pathway can cause anti-apopto

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of VGLL4 gene in treatment of tumors and related medicament of VGLL4 gene
  • Application of VGLL4 gene in treatment of tumors and related medicament of VGLL4 gene
  • Application of VGLL4 gene in treatment of tumors and related medicament of VGLL4 gene

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0091] Example 1 The relationship between the expression of VGLL4 and the occurrence and development of gastric cancer

[0092] 1. Experimental method

[0093] In order to study the clinical relationship between VGLL4 and YAP, the mRNA levels of VGLL4 and YAP in 84 human gastric cancer samples and 91 normal human gastric tissue samples were detected. Guanidine isothiocyanate is used to extract total RNA in one step. AMV reverse transcriptase synthesizes the first strand and uses it as a template to perform PCR amplification with corresponding primers under the action of DNA taq enzyme; PCR primers are shown in Table 1, Realtime -The PCR reaction system is shown in Table 2, the Realtime-PCR amplification program is shown in Table 3, and the PCR amplification results are shown in figure 1 A and figure 1 B.

[0094] Table 1 Primer sequence

[0095]

[0096] Table 2 Realtime-PCR reaction system

[0097]

[0098] Table 3 PCR reaction system program setting

[0099]

[0100] A tumor sample o...

Example Embodiment

[0106] Example 2 VGLL4 inhibits YAP-mediated TEAD4 transcriptional activation and cell proliferation

[0107] 1. The purpose of the experiment

[0108] The purpose of this example is to study the regulation modes of VGLL4, YAP and TEAD4 and their influence on cell proliferation.

[0109] 2. Experimental method

[0110] 2.1 Plasmid construction

[0111] 1) Construction of pCDH-YAP plasmid and pCDH-VGLL4 plasmid: One-step extraction of total RNA from human HEK293 cells with guanidine isothiocyanate, AMV reverse transcriptase to synthesize the first strand, and use it as a template for high-fidelity DNA polymerization in Takara Enzyme PrimeSTAR Use the corresponding primers to perform PCR amplification under the action of, the PCR primers are shown in Table 4, the PCR reaction system is shown in Table 5, and the PCR amplification program is shown in Table 6.

[0112] Table 4 Primer sequence

[0113]

[0114] Table 5 PCR reaction system

[0115]

[0116] Table 6 PCR amplification program

[0...

Example Embodiment

[0137] Example 3 Vgl4-TEAD4 interaction affects Vgl4 inhibits YAP-mediated transcriptional activation of TEAD4 and its downstream genes

[0138] 1. Experimental materials

[0139] 1.1 Construction of plasmid

[0140] 1) HT-pET-28a vector: Take commercial pET-28a (Novagen) as a template and use the following primers for construction. The PCR amplification program is: 98°C 2min; PCR cycle: 98°C 10s, 58°C 10s, 68°C 1kb / min, 18 cycles; 68°C 10min. Use DpnI demethylase to remove the unmutated wild-type pET28a template, transform the PCR amplified fragment into DH5α competent cells, and use the characteristic of repairing vector deletion in E. coli itself to circularize the entire fragment to form a vector through resistance After screening, the obtained HT-pET-28a vector with the same backbone as the original pET28a vector, but with TEV restriction sites and commonly used multiple cloning sites.

[0141] HT-s:

[0142] 5’-Gaaaacctgtattttcagggcgccatggatccggaattcaaaggcctacgtcgacgagctcaactag...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of biotechnology, and in particular relates to an application of a VGLL4 gene in treatment of tumors and a related medicament of the VGLL4 gene. The invention discloses a separated VGLL4 gene and a homologous sequence thereof, a VGLL4 protein and an application of related protein of the VGLL4 protein in preparation or screening of tumor treatment medicaments. Researches discover that VGLL4 can inhibit the transcription of a TEAD4 target gene CDX2 highly expressed in stomach cancer by inhibiting YAP-mediated TEAD4 transcriptional activation, thereby achieving the aim of inhibiting proliferation of cancer cells at last. The VGLL4 gene provided by the invention can be used for preparing medicaments for inhibiting the growth of tumor cells, developing anti-cancer medicaments and preparing medicaments for early diagnosis of cancer and medicaments for operation prognosis, so that the VGLL4 gene provides a new technical means for treating cancers, and has a great market value.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the use of VGLL4 gene in treating tumors and related medicines. Background technique [0002] Gastric cancer is the second most common cancer in the world after lung cancer, with poor prognosis and high mortality. However, the molecular mechanism of gastric cancer is still unclear, and there is no effective detection method to detect early gastric cancer. The proto-oncogenes and tumor suppressor genes related to gastric cancer still need to be further studied. [0003] In recent years, studies have found that the key transcriptional coactivator YAP in the Hippo signaling pathway is significantly upregulated in lung cancer, liver cancer, colon cancer, pancreatic cancer, and breast cancer, and is a proto-oncogene. [0004] The Hippo signaling pathway is involved in physiological processes such as cell proliferation, cell differentiation, and apoptosis, and plays a vital role in the re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K48/00A61K38/19C07K14/715C07K7/06C12Q1/68A61P35/00
Inventor 周兆才张雷季红斌赵允
Owner CENT FOR EXCELLENCE IN MOLECULAR CELL SCI CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products